ANAC up 15.95% after CFO buy reported by InsiderCow.
Parker Geoffrey M. of Anacor Pharmaceuticals, Inc. (Nasdaq: ANAC) bought Shares of ANAC.
Trade amount: 50,000 Shares
Trade type: Open Market Buy
Price Range: 8.61-9.93
Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=ANAC Get real-time alert on any insider trading information from www.insidercow.com, one step before everybody else.
InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.
Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The companys lead product candidates include tavaborole, an antifungal product candidate that is in Phase III clinical development for the treatment of onychomycosis; and AN2728, an anti-inflammatory product candidate, which completed Phase II clinical trials for the treatment of atopic dermatitis and psoriasis.
Disclosure: Insidercow.com is not a registered investment adviser or broker/dealer. Insidercow.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.